
Cost-Effectiveness of Interferon Beta-1a, Interferon Beta-1b, and Glatiramer Acetate in Newly Diagnosed Non-primary Progressive Multiple Sclerosis
Lisa A. Prosser, Karen M. Kuntz, Amit Bar-Or, Milton C. WeinsteinVolume:
7
Année:
2004
Langue:
english
Pages:
15
DOI:
10.1111/j.1524-4733.2004.75007.x
Fichier:
PDF, 242 KB
english, 2004